Inflammatory Cytokines Induce Endothelial Cells to Produce and Release Basic Fibroblast Growth Factor and to Promote Kaposi's Sarcoma-Like Lesions in Nude Mice

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1887-1894

  Samaniego, Felipe ^a,b   Markham, Phillip D ^c   Gendelman, Rita ^b   Gallo, Robert C ^a,b   Ensoli, Barbara ^b,d  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; INTERLEUKIN 1; MITOGENIC AGENT; PLASMIN; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL COUNT; CELL DEATH; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IMMUNOLOGY; KAPOSI SARCOMA; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; MICROCIRCULATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; SKIN; T LYMPHOCYTE; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CELL COUNT; CELL DEATH; CULTURE MEDIA, CONDITIONED; CYTOKINES; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERLEUKIN-1; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, NUDE; MICROCIRCULATION; MITOGENS; NEOVASCULARIZATION, PATHOLOGIC; PLASMIN; SARCOMA, KAPOSI; SKIN; T-LYMPHOCYTES; THROMBIN; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0031568523     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Safai, B., K. G. Johnson, P. L. Myskowski, B. Koziner, S. Y. Yang, S. Cunningham-Rundles, J. H. Godbold, and B. Dupont. 1985. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:744.
2. Jaffe, H. W., K. Choi, P. A. Thomas, H. W. Haverkos, D. M. Auerbach, M. E. Guinan, M. F. Rogers, T. J. Spira, W. W. Darrow, M. A. Kramer, S. M. Friedman, J. M. Monroe, A. E. Friedman-Kien, L. J. Laubenstein, M. Marmor, B. Safai, S. K. Dritz, S. J. Crispi, S. L. Fannin, J. P. Orkwis, A. Kelter, W. R. Rushing, S. B. Thacker, and J. W. Curran. 1983. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men. Part 1: Epidemiologic results. Ann. Intern. Med. 99:145.
3. Ruszczak, Z., A. Mayer-Da Silva, and C. E. Orfanos. 1987. Kaposi's sarcoma in AIDS: multicentric angioneoplasia in early skin lesions. Am. J. Dermatopathol. 9:388.
4. Gendelman, R., V. Fiorelli, V. Kao, R. C. Gallo, and B. Ensoli. 1994. Spindle cells from both AIDS-associated and classical Kaposi's sarcoma (KS) lesions are of endothelial cell origin and present an activated phenotype. AIDS Res. Hum. Retroviruses 10:S101 (Abstr.).
5. Zhang, Y.-M., S. Bachmann, C. Hemmer, J. van Lunzen, A. von Stemm, P. Kern, M. Dietrich, R. Ziegler, R. Waldherr, and P. P. Nawroth. 1994. Vascular origin of Kaposi's sarcoma: expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am. J. Pathol. 144:51.
6. Regezi, J. A., L. A. MacPhail, T. E. Daniels, Y. G. DeSouza, J. S. Greenspan, and D. Greenspan. 1993. Human immunodeficiency virus-associated oral Kaposi's sarcoma: a heterogeneous cell population dominated by spindle-shaped endothelial cells. Am. J. Pathol. 143:240.
7. McNutt, N. S., V. Fletcher, and M. A. Conant. 1983. Early lesions of Kaposi's sarcoma in homosexual men: an ultrastructural comparison with vascular proliferation in skin. Am. J. Pathol. 111:62.
8. Barillari, G., L. Buonaguro, V. Fiorelli, J. Hoffman, F. Michaels, R. C. Gallo, and B. Ensoli. 1992. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149:3727.
9. Levy, J. A., and J. L. Ziegler. 1983. Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet 2:78.
10. Samaniego, F., P. D. Markham, R. C. Gallo, and B. Ensoli. 1995. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J. Immunol. 154:3582.
11. Fiorelli, V., R. Gendelman, F. Samaniego, P. D. Markham, and B. Ensoli. 1995. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma cells. J. Clin. Invest. 95:1723.
12. Hober, D., A. Haque, P. Wattre, G. Beaucaire, Y. Mouton, and A. Capron. 1989. Production of tumour necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) in patients with AIDS: enhanced level of TNF-α is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78:329.
13. Lepe-Zanuga, J. L., P. W. A. Mansell, and E. M. Hersh. 1987. Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J. Clin. Microbiol. 25:1695.
14. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151:5031.
15. Senaldi, G., M. Peakman, C. Natoli, M. J. Hussain, H. Gallati, T. McManus, D. Vergani, and S. Iacobelli. 1994. Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus. J. Infect. 28:31.
16. + cell levels. J. Infect. Dis. 170:775.
17. + cells in HIV-1-infected and high risk individuals. Clin. Immunol. Immunopathol. 73:252.
18. DePauli, P., C. Caffau, M. D'Andrea, M. Tavio, U. Tirelli, and G. Santini. 1994. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma. J. Acquired Immune Defic. Syndr. 7:695.
19. Mitsuyasu, R. T. 1994. Clinical aspects of AIDS-related Kaposi's sarcoma. In Current Review of Oncology. M. D. Abeloff and J. Klastersky, eds. Current Science, Baltimore, MD, p. 835.
20. Krigel, R. L., K. A. Padavic-Shaller, A. R. Rudolph, B. J. Poiesz, and R. L. Comis. 1989. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and β-interferon: results of a phase 2 study. J. Biol. Response Modif. 8:359.
21. Aboulafia, D., S. A. Miles, S. R. Saks, and R. T. Mitsuyasu. 1989. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J. Acquired Immune Defic. Syndr. 2:54.
22. Oxholm, A., P. Oxholm, H. Permin, and K. Bendtzen. 1989. Epidermal tumour necrosis factor a and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. APMIS 97:533.
23. Moore, P. S., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma patients with or without HIV infection. N. Engl. J. Med. 332:1181.
24. Yamamoto, T., T. Osaki, K. Yoneda, and E. Ueta. 1993. Immunological investigation of adult patients with primary herpes simplex virus-1 infection. J. Oral. Pathol. Med. 22:263.
25. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and the HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674.
26. Yang, J., Y. Xu, C. Zhu, M. K. Hagan, T. Lawley, and M. K. Offermann. 1994. Regulation of adhesion molecule expression in Kaposi's sarcoma cells. J. Immunol. 152:361.
27. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
28. Ensoli, B., S. Nakamura, S. Z. Salahuddin, P. Biberfeld, L. Larsson, B. Beaver, F. Wong-Staal, and R. C. Gallo. 1989. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223.
29. Salahuddin, S. Z., S. Nakamura, P. Biberfeld, M. H. Kaplan, P. D. Markham, L. Larsson, and R. C. Gallo. 1988. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 242:430.
30. Ensoli, B., P. Markham, V. Kao, G. Barillari, V. Fiorelli, R. Gendelman, M. Reffeld, G. Zon, and R. C. Gallo. 1994. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotides targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J. Clin. Invest. 94:1736.
31. Xerri, L., J. Hassoun, J. Planche, V. Guigou, J.-J. Grob, P. Parc, D. Birnbaum, and O. deLapeyriere. 1991. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am. J. Pathol. 138:9.
32. Kandel, J., E. Bossy-Wetzel, F. Radvanyi, M. Klagsbrun, J. Folkman, and D. Hanahan. 1991. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095.
33. Rogelj, S., R. A. Weinberg, P. Fanning, and M. Klagsbrun. 1988. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331:173.
34. Daniel, W. W. 1978. Biostatistics: A Foundation for Analysis in the Health Sciences. John Wiley & Sons, New York, p. 499.
35. Richardson, M., S. Tinlin, M. De Reske, S. Webster, Y. Senis, and A. R. Giles. 1994. Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivo. Arterioscler. Thromb. 14:990.
36. Collins, P. W., M. G. Macey, M. R. Cahill, and A. C. Newland. 1993. von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells. Thromb. Haemost. 70: 346.
37. Benezra, M., I. Vlodavsky, R. Ishai-Michaeli, G. Neufeld, and R. Bar-Shavit. 1993. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 81:3324.
38. Singh, R. K., N. Liansa, C. D. Bucana, R. Sanchez, A. Koura, and I. J. Fidler. 1996. Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells. Cell Growth Differ. 7:397.
39. Tannenbaum, S. H., and H. R. Gralnick. 1990. γ-Interferon modulates von Willebrand factor release by cultured human endothelial cells. Blood 75:2177.
40. Janier, M., B. Flageul, L. Drouet, M.-L. Scrobohaci, J.-M. Villette, A. Palangie, and F. Cottenot. 1988. Cutaneous and plasma values of von Willebrand factor in AIDS: a marker of endothelial stimulation? J. Invest. Dermatol. 90:703.
41. Lafeuillade, A., M. C. Alessi, I. Poizot-Martin, C. Boyer-Neumann, C. Zandotti, R. Quilichini, L. Aubert, C. Tamalet, I. Juhan-Vague, and J. A. Gastaut. 1992. Endothelial cell dysfunction in HIV infection. J. Acquired Immune Defic. Syndr. 5:127.
42. Hodak, E., A. Trattner, M. David, N. Kornbrot, B. Modan, H. Lurie, A. Lawrie, P. Harrison, M. Sandbank, and A. Inbal. 1993. Quantitative and qualitative assessment of plasma von Willebrand factor in classic Kaposi's sarcoma. J. Am. Acad. Dermatol. 28:217.
43. Nguyen, H. C., B. M. Steinberg, M. LeBoutillier, F. G. Baumann, D. B. Rifkin, E. A. Grossi, and A. C. Galloway. 1994. Suppression of neointimal lesions after vascular injury: a role for polyclonal anti-basic fibroblast growth factor antibody. Surgery 116:456.
44. Moffet, J., E. Kratz, R. Florkiewicz, M. K. Stachowiak. 1996. Promoter regions involved in density-dependent regulation of basic fibroblast growth factor gene expression in human astrocytic cells. Proc. Natl. Acad. Sci. USA 93:2470.
45. Pober, J. S., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol Rev. 79:427.